A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

Clinical trial NCT06226714 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06226714
Sponsor: CanSino Biologics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Meningitis

Start date: 2024-03-01
Primary completion: 2024-09-26
Enrollment: 840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.